In hepatocellular carcinoma, Del Campo et al.25and Choi and Roberts26 corroborated findings reaffirming the direct action of MET in AMPK induction, mTOR inhibition, cell cycle suppression and the consequent proliferation of tumor cells. Here, MTOR is linked to hepatocellular carcinoma.